Respiratory Care Equipment

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2606E04] MEKICS is a company that pioneers a new medical paradigm by expanding the value-chain of respiratory care services, based on its proprietary technology and accumulated achievements.
MEKICS is committed to improving patient-treatment success rates through continuous clinical enhancements and developing innovative products that reflect various medical environments and needs.

Multiple Respiratory Therapy Device
MEKICS’ OmniOx overcomes the limitations of conventional oxygen therapy by providing an innovative solution that adapts flexibly to various patients and conditions with a single device. Designed for use beyond hospitals, it ensures seamless oxygen therapy wherever it is needed, without spatial constraints.
Equipped with a blower, heated humidifier, and built-in oxygen blender, OmniOx is the world’s first device to integrate heated humidified high-flow nasal cannula (HFNC) therapy with CPAP and dual-level non-invasive ventilation (NIV) modes. This enables safe and effective ventilation therapy across diverse environments, from hospitals to home care.

Portable Ventilator
MEKICS’ MV50 is designed to provide essential functions required by clinicians for optimized ventilation, based on various conditions and treatment environments, for both pediatric and adult patients.
It provides flexibility ranging from the intensive care unit to free movement within the hospital, providing the treatment environment desired by clinicians. With MEKICS’ portable ventilator, you can experience the power of personalized solutions and clinically proven methods.
As the global population is aging rapidly, the importance of respiratory-disease management is becoming increasingly critical ― particularly in developed countries where homecare and senior living communities require specialized solutions. In response, MEKICS is developing an integrated service-management system that enables effective respiratory care not only in medical institutions, but also at the individual and community levels.
Beyond being a mere medical-device manufacturer, MEKICS strives to be a trusted partner for both patients and healthcare professionals through relentless research, development, and quality innovation.

“To become a global leader in the field of respiratory therapy, MEKICS will continue to provide next-generation medical solutions incorporating cutting-edge technology, creating value for a healthier and better life,” a spokesperson for the company remarked.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With: , ,

Digital Diagnostic X-Ray Systems

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2606E03] Since its establishment in September 2003, DRGEM Corporation has been dedicated exclusively to the field of X-ray imaging, offering a comprehensive range of solutions for general diagnostic X-ray systems.
Through continuous research, development, and product innovation, DRGEM delivers exceptional X-ray equipment while fulfilling its responsibilities and commitments to its customers, and thereby ensuring their utmost satisfaction.

Auto Positioning System, based on the GXR-SD Digital X-ray System, offers fully automated tracking and positioning for the wall stand and table, thus enhancing workflow efficiency and patient care.
The Auto Positioning System streamlines workflow with fully automated tracking and positioning features, enhancing throughput and improving the experience for both patients and operators by allowing greater focus on patient care.
This motorized system ensures precise and effortless positioning for both the wall stand and table, delivering fast and accurate movements. Integrated with the pre-programmed RADMAX procedure and automated RADMAX image processing, it maximizes efficiency and delivers consistent, high-quality imaging results.

Fully Automated Motor-driven System
Motorized movements across all axes enable fast, accurate positioning with minimal manual input. Predefined positions ensure consistent imaging and streamlined workflow.
A large touchscreen console provides clear visuals and intuitive operation, allowing faster adjustments and improved workflow control.
Ergonomic design and wide-range movement offer easy access to patients and smooth, accurate positioning for various examinations.

Built-in safety sensors prevent collisions by detecting obstacles near the wall Bucky, tube stand, and table. Emergency stop switches at key points allow quick response, ensuring a safe environment for both patients and staff.
The system’s auto rotating touch screen console enhances flexibility and usability by allowing effortless screen rotation, enabling operators to access and control key system functions from various angles, ensuring a seamless workflow.
DRGEM recently completed its successful participation at EXPOSANITA 2026 in Bologna. This premier European event offered a fantastic opportunity to meet leading Italian medical professionals. The company engaged with many global partners to discuss the latest trends in diagnostic imaging at EXPOSANITA 2026. Throughout the event, DRGEM shared its vision for the future of radiology with dedicated industry experts.

Moving Closer to Developing AI-Based Low-Dose C-Arm ‘PROVUE’
DRGEM recently announced that it is driving innovation in the field of fluoroscopy ― technology that uses X-rays to visualize the inside of the human body in real time ― by incorporating artificial intelligence (AI) into image-processing technology for C-arm equipment.

Known as PROVUE, this device analyzes X-ray images acquired at low doses using an AI-based denoising algorithm to remove image noise, thereby significantly reducing radiation exposure for both patients and physicians.
Minimizing X-ray dose during real-time observation of the human body has long been a key technical challenge in fluoroscopy, and achieving high image-quality in a low-dose environment remains a technically difficult task.
A spokesperson for DRGEM explained that the company has achieved tangible results by developing AI-powered image-processing technology through joint research with KAIST.
In particular, this technology has further improved image-noise removal performance by training the AI not only on random noise, but also on real noise data generated in actual clinical environments. DRGEM revealed that through the AI denoising technology applied to PROVUE, it has confirmed the potential to achieve a similar level of image quality at a radiation dose approximately 70% lower than conventional methods.
DRGEM’s CEO explained, “PROVUE is a device developed with a dual focus on enhancing the convenience of medical staff and ensuring the safety of both medical staff and patients,” adding, “We plan to continue developing technology to simultaneously improve the usability and image quality of medical-imaging equipment in the future.”

DRGEM anticipates that technology development will be completed and the product will enter the market in the second half of 2026.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With: ,

Laser Medical Devices

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2606E02] Lameditech Co., Ltd. is a specialized laser medical device company established in 2012. Based on its miniaturized laser technology, Lameditech develops, manufactures, and supplies products that contribute to a healthier and more beautiful life for all.
Its key products include the HandyRay series, which enables peripheral blood sampling without needles, and CAREVEAM, a 308nm excimer laser device for treating skin diseases. Additionally, Lameditech has developed Ray-Vet, a laser-treatment device for pets’ skin ailments.

Blood Sampling Device
Lameditech’s HandyRay series is an innovative blood-sampling device that utilizes lasers to collect peripheral blood without the use of needles. This product overcomes the drawbacks of traditional needle-based lancets by offering advantages such as reduced pain, elimination of secondary infection risks, and prevention of callus formation or needle marks.
Notably, it minimizes discomfort for diabetic patients who require frequent blood glucose monitoring and provides safe and hygienic blood collection for patients of all ages, including newborns. The HandyRay series is available in various models, ranging from personal to hospital and medical institution use, allowing users to choose a suitable model according to their needs.

Home Skincare Device
Lameditech’s PURAXEL is an innovative home-skincare device that brings fractional laser technology from clinics to home use. It combines laser, ultrasound, galvanic, cooling, and LED functions to enhance skin improvement.
Its laser micro-hole technology creates tiny openings in the skin, thereby promoting regeneration and boosting nutrient absorption. This stimulates collagen production, improving elasticity, wrinkles, and skin tone.
Each shot generates about 100 micro-laser holes, thus maximizing absorption while minimizing pain and side effects. Users can enjoy professional skincare at home without the cost, downtime, or discomfort of clinic treatments.

With outstanding technology and reliable quality, Lameditech has gained recognition in both domestic and international markets. The company continues to focus on research and development to lead the global healthcare industry.
“We are also making strides in the beauty-device market with our innovative products, and we remain committed to continuous research and quality improvement for customer satisfaction and to contribute to the growth of the global beauty industry,” remarked a spokesperson for the company.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With: , ,

Korean Exporters Breaking their All-Time Monthly Record

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Releasing New Competitive Exports Items


 Korea’s exports in May 2026 reached $87.75 billion, breaking the all-time monthly record. Driven by a super-cycle of demand, the semiconductor sector also recorded its highest-ever performance, offsetting the effect of reduced working days due to the holidays.
Monthly exports have exceeded $80 bil. for three consecutive months since first surpassing the $80 bil. mark in March.
Despite the reduced number of working days, exports hit a record high, with the daily average export value rising by 60.7% to $4.28 bil. This marks the first time the figure has surpassed the $4 bil. mark.

Semiconductors were once again the driving force behind exports this month. Semiconductor exports in May reached $37.15 bil., a 169.4% increase from the same month last year, marking an all-time high as they surpassed $30 bil. for the third consecutive month.
Exports of non-semiconductor items also showed a steep upward trend, rising by an average of 16%.
Korean exporters are ceaselessly releasing new products. Towards accomplishing their export performance goals for this year, creative efforts are being made to pioneer their own potential buyers and markets.
MEKICS’ OmniOx overcomes the limitations of conventional oxygen therapy by providing an innovative solution that adapts flexibly to various patients and conditions with a single device. Designed for use beyond hospitals, it ensures seamless oxygen therapy wherever it is needed, without spatial constraints.

BE&BI Tech’s UCOS-HIFU effectively removes wrinkles and lifts the skin without direct surgical procedures. As an indirect treatment, it minimizes damage to the skin surface and has no side effects. With a short treatment time of 10 to 30 minutes, it improves skin elasticity and reduces fine wrinkles. What’s more, users can resume daily activities immediately after the procedure.


 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Needle-Free Injector

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2605E05] JSKBIOMED Inc. is a biomedical company specializing in laser-based, needle-free injection technology, developing next-generation drug delivery solutions that address the limitations of conventional injection methods ― including pain, infection risk, and medical-waste generation.
Based on proprietary technology that precisely controls the skin barrier using laser energy, the company has established a platform capable of effectively delivering drugs, vaccines, and functional substances, with scalability across medical, aesthetic, and healthcare fields.

Following the stabilization of its core technology in 2025, JSKBIOMED has begun full-scale expansion into overseas markets, entering major countries including Japan, Poland, and Sweden. In Korea, the technology is currently being applied in approximately 300 hospitals and clinics, thereby, demonstrating both technical stability and clinical applicability.
JSKBIOMED recently introduced its laser-based, needle-free injection technology and new product lineup ― aiming to expand strategic partnerships with overseas distributors, medical device companies, and pharmaceutical and biotech firms. The company has been seeking to release collaboration models tailored to country-specific distribution structures and market characteristics while building long-term global networks.
JSKBIOMED’s flagship medical product, MiraJet, utilizes laser-based needle-free injection technology to deliver drugs and active ingredients effectively while minimizing skin damage. It is designed to reduce pain and infection risk while lowering dependency on practitioner skill, thereby enabling a more consistent treatment environment.
JSKBIOMED also recently introduced its aesthetic equipment Jetical Pro 2940, which presents a solution optimized for professional treatment settings. Based on precise laser- control technology, it supports stable energy delivery and enhanced treatment control, and is designed to improve skin condition and increase the efficiency of active ingredient delivery. It can be applied to various skin types and treatment purposes, expanding its usability in professional clinics.

In addition, JSKBIOMED is expanding into the homecare market with the Jetical Mini Pro, a consumer device that integrates the core technology of its medical and professional equipment. Designed with enhanced usability and safety, it enables personalized skincare management, forming an integrated laser-based needle-free injection solution ecosystem across medical, professional, and home-use categories.
JSKBIOMED has identified the United States, Japan, China, France, and Germany as key target markets. These countries represent mature medical and aesthetic device markets with continuously increasing demand for high-performance and high-value aesthetic technologies. The company plans to pursue phased market expansion through collaboration with local buyers, distributors, and global beauty and biotech companies.
In the first half of 2026, JSKBIOMED will be participating in major international exhibitions such as AMWC Monaco and ASLMS in order to strengthen global brand recognition, while promoting its technology and expanding partnerships.
At the same time, JSKBIOMED will pursue country-specific regulatory approvals and certifications in stages and accelerate its growth as a global laser-based needle-free injection platform company through technology licensing, joint development, and diversified collaboration models.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

AI-based Personalized Pelvic-Wellness Platform

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2605E04] MBLab is an innovative technology company that develops solutions to improve women’s quality of life through AI- and data-based digital healthcare technologies. Focusing on women’s pelvic health and wellness (Pelvic Wellness), the company combines medical expertise with user experience to expand its presence in the global Femtech market.
With the vision of understanding women through AI and data, and redefining health in life, MBLab aims to evolve into a personalized health management platform.
MBLab’s core mission is built on scientific, evidence-based technology development, user-centered health experience design, and global market expansion. By utilizing data and AI, the company develops personalized health solutions while incorporating the insights of medical professionals to deliver practical wellness experiences. At the same time, it is accelerating global expansion through overseas distribution and strategic partnerships.

In Korea, MBLab has already supplied its VVP3500 diagnostic device and RT4000 urinary incontinence treatment system to 250 hospitals, where they are actively used in clinical settings.

In Japan, MBLab has exported its AI- and data-based pelvic-health solution Ekegel, thereby establishing a foothold in the market. Through participation in MEDICA 2025 and CES 2026, the company has drawn interest from global buyers, and is advancing its international marketing efforts.
MBLab recently introduced locally not merely a conventional Kegel device, but an AI-based personalized Pelvic Wellness Platform. The solution is structured as an intelligent pelvic floor management system that integrates measurement, analysis, personalized exercise, and feedback. It analyzes contraction, endurance, and relaxation data, incorporates a 12-item vaginal health checklist, classifies users based on AI algorithms, and automatically sets optimal exercise intensity tailored to each individual.
The platform is positioned as a clinically recognized product used in hospitals and medical channels. By going beyond a simple exercise device and providing a data-driven continuous management system, it enhances the precision of women’s health management. It is applicable to various conditions, including urinary incontinence, postpartum recovery, and pelvic health management for middle-aged women.
MBLab aimed at increasing awareness of AI-based pelvic health solutions in the domestic healthcare market, discovering hospital, clinic, and distribution partners, and gathering feedback from medical professionals in order to further refine its products. At the same time, the company seeks to strengthen domestic references to support its global expansion strategy.
MBLab’s global strategy will proceed in three phases: first, establishing a foundation for entry into the North American market; second, expanding in Japan and securing entry opportunities in Europe; and third, targeting premium markets in the Middle East and China.
Following participation in MEDICA 2025 and CES 2026, MBLab plans to attend CES 2027 and healthcare exhibitions in Dubai, while continuing to expand its domestic and international network through participation in future KIMES events.
Through its AI-based personalized pelvic-health management platform, MBLab aims to present a new standard in women’s wellness and strengthen its competitiveness in the global Femtech market as a data-driven technology company.


 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Digital Therapeutics

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Accelerating Global DTx Market Expansion
[INQ. NO. 2605E03] Beyondmedicine Co., Ltd. is an AI-based Digital Therapeutics (DTx) company founded in 2022, developing prescription-based digital treatment solutions focused on chronic and recurrent Temporomandibular Disorder (TMD).
Recognizing that TMJ disorders are difficult to manage through single, clinic-centered treatments alone, Beyondmedicine has introduced its core product, ClicklessDTx, a digital therapeutic designed to improve patients’ daily behavioral correction and treatment adherence.
By integrating Cognitive Behavioral Therapy (CBT) technology, the platform objectively collects and analyzes patients’ rehabilitation exercise performance and symptom changes ― providing an integrated digital-treatment system that enables clinicians to manage treatment progress beyond the clinic.
Through ClicklessDTx, Beyondmedicine conducted the world’s first Randomized Controlled Trial (RCT) targeting temporomandibular disorder patients and published the results in the SCI-indexed international Journal of Dentistry, thereby demonstrating its clinical efficacy.

It also obtained designation as an Innovative Medical Device from the Korean Ministry of Food and Drug Safety (MFDS), becoming the first digital therapeutic device in the dental field to receive such recognition in Korea. The company has completed domestic medical device approval for its TMJ digital therapeutic device. Overseas, it completed the U.S. FDA Pre-submission process and received recognition as a Novel Technology, thus securing a foundation for global regulatory approval.
Beyondmedicine recently presented a hospital-prescription-based digital-treatment model centered on ClicklessDTx. It emphasized that the solution can operate in conjunction with conventional physical therapy, thereby simultaneously improving hospital-treatment efficiency and revenue structure. Locally, it showcased real clinical data and a clinician-exclusive dashboard to explain product differentiation and practical application, while seeking early-adopter medical institutions and global partners.

ClicklessDTx is a prescription-based digital-treatment system integrating into a single platform home-based rehabilitation, behavior modification, symptom tracking, treatment feedback, and clinical reporting. Patients perform therapeutic programs in daily life while accumulating data, and clinicians can systematically monitor treatment progress and adherence outside the hospital through a dedicated clinician dashboard. The system is designed to complement the limitations of episodic treatment and enhance treatment continuity and management efficiency.
Users are expected to achieve clinically validated improvements through 5–10 minutes of daily program participation over six weeks. The treatment process is visualized through data-based interfaces, allowing both patients and clinicians to intuitively track therapeutic changes.
Beyondmedicine has identified the United States, Japan, and major European countries as key target markets. The United States represents a high-acceptance market with an established regulatory framework for digital therapeutics, and the company is pursuing initial entry based on FDA approval procedures. Japan faces increasing demand for chronic pain and rehabilitation solutions due to population aging, while Europe’s evidence-based healthcare system provides a favorable environment for RCT-based digital therapeutic adoption.
Going forward, Beyondmedicine plans to advance full-scale commercialization of ClicklessDTx in Korean hospitals and gradually expand global market entry in accordance with U.S. FDA regulatory processes. The company will also strengthen global partnerships through participation in international dental and digital health exhibitions and conferences, while expanding its pipeline beyond TMJ digital therapeutics into facial paralysis rehabilitation and broader dental and oral healthcare areas. To support this expansion, the company is preparing for Series-A investment fundraising.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Photorealistic 3D Avatar-Based Body-Analysis Solution

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2605E02] VBody was founded by the Yonsei University Computer Graphics Lab to address the subjectivity of body-shape assessments and the inconsistencies in tracking physical changes that frequently occur in fitness centers, Pilates studios, and clinics.
Traditional visual assessments and 2D photo-based consultations often vary, depending on the evaluator, resulting in inconsistent explanations and reduced persuasiveness when presenting before-and-after results. Leveraging computer-vision and 3D neural rendering-based human digitization technology, VBody has commercialized a solution that generates photorealistic 3D avatars and standardized body metrics from a simple capture process, enabling not just ‘visible change’ but also ‘measurable and explainable change.’
Since its official launch in December 2025, VBody has established a nationwide sales and supply system, offering packaged solutions that combine 3D scanning hardware and AI-powered body-analysis software to B2B clients including fitness centers, Pilates studios, and clinics. On-site workflows ― from capture, to 3D avatar generation, body metric calculation, and before-and-after comparison reporting ― have been standardized to minimize operational burdens.
VBody recently introduced its technology locally, as a solution capable of simultaneously achieving objective body and posture evaluation and enhanced patient communication in medical and healthcare settings. The company emphasizes that its photorealistic 3D avatars and AI-based analytical metrics generated from brief capture sessions can shorten consultation times, while presenting treatment and exercise outcomes according to consistent standards.
VBody’s body-analysis and change-tracking solution enhances consultation persuasiveness through 3D visualization and provides AI-based standardized metrics, ensuring consistent evaluation, explanation, and tracking regardless of practitioner or branch location. Objective data is delivered by posture estimation-based key-point analysis, joint and trunk-angle measurements, and proportional indicators ― while accumulated longitudinal data and before-and-after comparison reports intuitively demonstrate treatment and exercise outcomes. This approach has attracted industry interest for its potential to support re-visits and re-registration performance.

VBody has identified the United States, Japan, and the Middle East as priority overseas markets. The United States represents a rapidly expanding market for digital health and data-driven fitness consultations. Japan, facing rapid aging, has strong demand for rehabilitation and posture correction and a high acceptance of standardized reporting. The Middle East is characterized by active investment in premium healthcare and fitness infrastructure, with growing interest in advanced equipment that enhances customer experience.
Looking ahead, VBody plans to expand nationwide distribution in 2026, while establishing a partnership framework capable of supporting repeat adoption. The company is preparing for global expansion with a target of participating in CES 2027. Based on domestic field references, VBody aims to further refine product completeness and establish a new standard for 3D-based body digitization in the global healthcare and fitness markets.

 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

AI-Based Smartwatch

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Targeting Both Industrial Safety and Elderly Care
[INQ. NO. 2605E01] Innomes is a technology company providing smart healthcare solutions designed to protect workers in industrial environments and vulnerable populations in densely populated settings.
Centered on its AI-powered smartwatch InnoCare System, Innomes is expanding simultaneously into industrial safety and elderly healthcare markets through an IoT smartwatch equipped with multi-sensor technology.
The InnoCare System collects and analyzes real-time biometric data via nine embedded sensors in the smartwatch, including heart rate and body temperature. The system is designed to detect early-warning signs of heatstroke, overexertion, and cardiac abnormalities ― particularly in high-temperature, high-humidity, or physically demanding work environments. Data is transmitted in real time to an AI-based integrated monitoring platform, where abnormal patterns trigger immediate alerts to administrators, thereby assisting in the prevention of serious industrial accidents.

Innomes successfully developed its safety and health management system for major accident prevention through the Ministry of SMEs and Startups’ Smart Manufacturing Innovation R&D Program. The solution has been supplied to small and medium-sized manufacturers in the Changwon National Industrial Complex and to Changwon Leports Park, thereby establishing domestic reference cases. Building on this foundation, the company signed MOUs with Thai manufacturing firms AOSSAWIN and SETTHAMOUSHOL in Bangkok through the Gyeongnam Changwon Defense Innovation Cluster overseas export support program, and is currently advancing discussions.
Innomes recently locally presented the InnoCare System as a first step toward establishing a safety and health management system under the Serious Accidents Punishment Act. Beyond industrial sites, the company will emphasize its scalability as a real-time health monitoring solution for elderly individuals living alone, and populations vulnerable to heat-related illnesses.
Through its administrator-mode integrated monitoring dashboard, the system enables comprehensive data analysis across worksites and supports AI-based predictive risk management.
Innomes has identified Thailand and Japan as key target markets for overseas expansion. Thailand is experiencing increasing smartwatch adoption and demographic aging, creating growing demand from elderly care facilities, hospitals, and healthcare institutions.
The company is pursuing collaboration with local medical firm Chalerm Prakarn Group and exploring potential partnerships with Bangkok Hospital and global medical tourism platforms.
Japan, one of the world’s most rapidly aging societies, presents strong demand for elderly health and safety management solutions. Innomes is preparing for market entry through a partnership with Omron Corporation and is strengthening localization strategies by collaborating with AI-based personalized care solution providers.
Starting in 2026, Innomes plans to participate sequentially in major domestic and international exhibitions including MEDICA, Medical Fair Asia, etc. Through these platforms, the company aims to expand its global buyer and partner network, establish regulatory and certification strategies for local markets, and accelerate overseas market entry aligned with customized product development.
By integrating industrial safety and elderly healthcare into a unified framework, Innomes seeks to build a data-driven preventive healthcare ecosystem powered by AI-based biometric monitoring technology.

 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Korea’s Exporters

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Korea’s Exporters Continuing Astounding Growth

Releasing Globally Competitive New Items

Korea’s exports have broken all-time records for the month of April, boosted by the global expansion of artificial intelligence (AI) infrastructure.
The nation’s exports in April recorded $85.89 billion, a 48.0% increase compared to the same month last year. Imports rose by 16.7% to $62.11 billion, resulting in a surplus of $23.77 billion in trade balance. With this, Korea set a record by surpassing $80 billion in exports and $20 billion in trade balance for the first time in history.

The undisputed star contributor was semiconductors. As global investment in AI infrastructure expanded, massive demand emerged for both NAND and DRAM, causing semiconductor exports to surge by a staggering 173.5% year-on-year to reach $31.9 billion. This marks the highest monthly record for the 13th consecutive month. The computer (SSD) sector also showed growth, increasing by 515.8% due to an explosion in demand for data centers driven by the spread of AI.

Korea’s Competitive New Items Attracting Keen Attention of Potential Buyers
Korean companies are ceaselessly launching new products. Striving to achieve their export performance goals for this year, creative efforts are being made to engage in the development of competitive products.
VBody recently introduced its technology locally, as a solution capable of simultaneously achieving objective body and posture evaluation and enhanced patient communication in medical and healthcare settings. The company emphasizes that photorealistic 3D avatars and AI-based analytical metrics generated from brief capture sessions can shorten consultation times, while presenting treatment and exercise outcomes according to consistent standards.

MBLab recently introduced locally not merely a conventional Kegel device, but an AI-based personalized Pelvic Wellness Platform. The solution is structured as an intelligent pelvic floor management system that integrates measurement, analysis, personalized exercise, and feedback. It analyzes contraction, endurance, and relaxation data, incorporates a 12-item vaginal health checklist, classifies users based on AI algorithms, and automatically sets optimal exercise intensity tailored to each individual.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:
«Previous Page
Next Page»